Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Hepatitis

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 147 articles: HTML format

Single Articles

July 2021
1. VAZ K, Little R, Majeed A, Kemp W, et al
   Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis.
   Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07140.
   PubMed     Abstract available
   
   
   June 2021
2. GELOW K, Chalasani S, Green K, Lammert C, et al
   Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
   Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
   PubMed     Abstract available
   
   
   May 2021
3. CHEN J, Hubbard A, Bagley L, Shiau R, et al
   Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2021 May 30. pii: 10.1007/s10620-021-07056.
   PubMed     Abstract available
   
   
   
4. LIN MH, Li HQ, Zhu L, Su HY, et al
   Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
   Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
   PubMed     Abstract available
   
   
   
5. HE WQ, Matthews GV, Liu B
   Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
   Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-07008.
   PubMed     Abstract available
   
   
   April 2021
6. LAMMERT C, Chalasani SN, Green K, Atkinson E, et al
   Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.
   Dig Dis Sci. 2021 Apr 30. pii: 10.1007/s10620-021-06989.
   PubMed     Abstract available
   
   
   
7. CZAJA AJ
   Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
   Dig Dis Sci. 2021 Apr 9. pii: 10.1007/s10620-021-06968.
   PubMed     Abstract available
   
   
   March 2021
8. LE E, Chee G, Kwan M, Cheung R, et al
   Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment.
   Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06941.
   PubMed     Abstract available
   
   
   February 2021
9. KANG N, Chung JW, Jang ES, Jeong SH, et al
   Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
   Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
   PubMed     Abstract available
   
   
   
10. JONES BE, Allegretti AS, Pose E, Mara KC, et al
    Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
    PubMed     Abstract available
    
    
    
11. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    PubMed     Abstract available
    
    
    
12. EVON DM, Kim HP, Edwards A, Carda-Auten J, et al
    "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.
    Dig Dis Sci. 2021 Feb 2. pii: 10.1007/s10620-021-06829.
    PubMed     Abstract available
    
    
    January 2021
13. KIM S, Yoo S, Lee JI, Kim S, et al
    Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance.
    Dig Dis Sci. 2021 Jan 30. pii: 10.1007/s10620-021-06845.
    PubMed     Abstract available
    
    
    
14. HONG SW, Choi WM, Hwang HW, Kim DS, et al
    Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06745.
    PubMed     Abstract available
    
    
    
15. KUO MH, Tseng CW, Lu MC, Tung CH, et al
    Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06725.
    PubMed     Abstract available
    
    
    October 2020
16. ROCCO A, Compare D, Risitano AM, Sgamato C, et al
    Bone Marrow of Contention: A Rare Case of Recurrent Acute Hepatitis.
    Dig Dis Sci. 2020 Oct 22. pii: 10.1007/s10620-020-06670.
    PubMed     Abstract available
    
    
    
17. SHAMSEDDEEN H, Madathanapalli A, Are VS, Shah VH, et al
    Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06632.
    PubMed     Abstract available
    
    
    September 2020
18. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
    Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
    Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
    PubMed     Abstract available
    
    
    
19. TERRAULT NA, Ghany MG
    Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06584.
    PubMed    
    
    
    
20. WINTERS AC, Kabany ME, Choi G, Saab S, et al
    Acute Liver Failure During Pregnancy: Happy to Recover from Hep E.
    Dig Dis Sci. 2020;65:2515-2517.
    PubMed    
    
    
    August 2020
21. FERRE-ARACIL C, Riveiro-Barciela M, Trapero-Marugan M, Rodriguez-Peralvarez M, et al
    Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06569.
    PubMed     Abstract available
    
    
    
22. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available
    
    
    
23. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    PubMed     Abstract available
    
    
    
24. CZAJA AJ
    Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 Aug 24. pii: 10.1007/s10620-020-06562.
    PubMed     Abstract available
    
    
    
25. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    PubMed     Abstract available
    
    
    July 2020
26. CHANG ML, Hu JH, Chen WT, Lin MS, et al
    Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels.
    Dig Dis Sci. 2020 Jul 31. pii: 10.1007/s10620-020-06507.
    PubMed     Abstract available
    
    
    
27. OHFUJI S, Matsuura T, Tamori A, Kubo S, et al
    Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan.
    Dig Dis Sci. 2020 Jul 27. pii: 10.1007/s10620-020-06475.
    PubMed     Abstract available
    
    
    
28. BENHAMMOU JN, Moon AM, Pisegna JR, Su F, et al
    Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C.
    Dig Dis Sci. 2020 Jul 11. pii: 10.1007/s10620-020-06457.
    PubMed     Abstract available
    
    
    
29. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    PubMed     Abstract available
    
    
    June 2020
30. BEN MERABET Y, Barbe C, Heurgue-Berlot A, Thevenot T, et al
    Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Dig Dis Sci. 2020 Jun 30. pii: 10.1007/s10620-020-06444.
    PubMed     Abstract available
    
    
    
31. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    PubMed     Abstract available
    
    
    May 2020
32. MCNALLY BB, Carey EJ
    Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06347.
    PubMed     Abstract available
    
    
    
33. DOSHI SD, Stotts MJ, Hubbard RA, Goldberg DS, et al
    The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06346.
    PubMed     Abstract available
    
    
    
34. HUYNH T, Hu KQ
    Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data.
    Dig Dis Sci. 2020 May 13. pii: 10.1007/s10620-020-06286.
    PubMed     Abstract available
    
    
    
35. YUEN MF, Liu SH, Seto WK, Mak LY, et al
    Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06281.
    PubMed     Abstract available
    
    
    April 2020
36. OUZAN D, Larrey D, Guyader D, Remy AJ, et al
    Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
    Dig Dis Sci. 2020 Apr 18. pii: 10.1007/s10620-020-06234.
    PubMed     Abstract available
    
    
    
37. CHAUHAN A, Kumar R, Sharma S, Mahanta M, et al
    Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study.
    Dig Dis Sci. 2020 Apr 11. pii: 10.1007/s10620-020-06246.
    PubMed     Abstract available
    
    
    
38. CAREY W
    Know When to Hold 'em, Know When to Treat 'em, Know When to Cut 'em: Why Severe Alcoholic Hepatitis Is Becoming a Surgical Disease.
    Dig Dis Sci. 2020 Apr 8. pii: 10.1007/s10620-020-06239.
    PubMed    
    
    
    
39. O'BEIRNE J
    Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
    Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.
    PubMed    
    
    
    
40. MUKHTAR NA, Evon DM, Yim C, Lok AS, et al
    Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06224.
    PubMed     Abstract available
    
    
    March 2020
41. ZHANG X, Ying Y, Zhou P, Liu X, et al
    A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06149.
    PubMed     Abstract available
    
    
    February 2020
42. MELLINGER JL, Stine JG
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
    PubMed     Abstract available
    
    
    
43. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
    A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
    PubMed     Abstract available
    
    
    
44. ILUZ-FREUNDLICH D, Samad N, Miles D, Osiowy C, et al
    Spontaneous Flares of Chronic Hepatitis B Virus in Hepatitis Be Antigen Negative Carriers Who Subsequently Clear Hepatitis B Surface Antigen.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06125.
    PubMed     Abstract available
    
    
    
45. WONG K, Podboy A, Lavezo J, Goel A, et al
    Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis.
    Dig Dis Sci. 2020;65:399-400.
    PubMed    
    
    
    January 2020
46. BENITEZ TM, Fernando SM, Amini C, Saab S, et al
    Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06073.
    PubMed     Abstract available
    
    
    
47. YANG L, Zhang Q, Song J, Wang W, et al
    Interleukin-35 Suppresses CD8(+) T Cell Activity in Patients with Viral Hepatitis-Induced Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06077.
    PubMed     Abstract available
    
    
    
48. VAN BOEMMEL-WEGMANN S, Lo Re V 3rd, Park H
    Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection.
    Dig Dis Sci. 2020 Jan 14. pii: 10.1007/s10620-019-06037.
    PubMed     Abstract available
    
    
    
49. YIK B, Shah N
    Autoconversion of Autoimmune Liver Diseases.
    Dig Dis Sci. 2020;65:71-73.
    PubMed    
    
    
    
50. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    PubMed    
    
    
    December 2019
51. MAHFOUZ M, Nguyen H, Tu J, Diaz CR, et al
    Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Dig Dis Sci. 2019 Dec 7. pii: 10.1007/s10620-019-05980.
    PubMed     Abstract available
    
    
    November 2019
52. CHEN Y, Ji H, Shao J, Jia Y, et al
    Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
    PubMed     Abstract available
    
    
    
53. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available
    
    
    
54. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available
    
    
    October 2019
55. HUANG R, Rao H, Yang M, Gao Y, et al
    Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
    PubMed     Abstract available
    
    
    
56. ZHANG G, Patel K, Moghe A, Reid A, et al
    Provider Perceptions of Hepatitis C Treatment Adherence and Initiation.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05877.
    PubMed     Abstract available
    
    
    
57. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available
    
    
    September 2019
58. O'BEIRNE J
    Readmission Following Hospitalization for Alcoholic Hepatitis: Costly or Cost-Effective?
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05854.
    PubMed    
    
    
    
59. WU SF, Tseng CW, Ho YC, Chen YC, et al
    Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05850.
    PubMed     Abstract available
    
    
    August 2019
60. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Abstract available
    
    
    
61. SAYINER M, Stepanova M, De Avila L, Golabi P, et al
    Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Dig Dis Sci. 2019 Aug 27. pii: 10.1007/s10620-019-05786.
    PubMed     Abstract available
    
    
    
62. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Abstract available
    
    
    
63. ALI RO, Moon MS, Townsend EC, Hill K, et al
    Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05760.
    PubMed     Abstract available
    
    
    
64. BURTON MJ
    In DAA We Trust: Key Factors Essential to HCV Elimination.
    Dig Dis Sci. 2019 Aug 6. pii: 10.1007/s10620-019-05748.
    PubMed    
    
    
    
65. JOSHI SS, Gao S, Castillo E, Coffin CS, et al
    Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Dig Dis Sci. 2019 Aug 2. pii: 10.1007/s10620-019-05745.
    PubMed     Abstract available
    
    
    
66. ADEJUMO AC, Cholankeril G, Iqbal U, Yoo ER, et al
    Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05759.
    PubMed     Abstract available
    
    
    July 2019
67. BLOOM PP, Mojtahed A, Bethea ED, Knooihuizen SA, et al
    Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.
    Dig Dis Sci. 2019 Jul 30. pii: 10.1007/s10620-019-05721.
    PubMed     Abstract available
    
    
    
68. MATHUR K, Vuppalanchi V, Gelow K, Vuppalanchi R, et al
    Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jul 30. pii: 10.1007/s10620-019-05756.
    PubMed     Abstract available
    
    
    
69. COSTENTIN CE, Sogni P, Falissard B, Barbare JC, et al
    Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Dig Dis Sci. 2019 Jul 25. pii: 10.1007/s10620-019-05724.
    PubMed     Abstract available
    
    
    
70. MAK LY, Liu SH, Yap DY, Seto WK, et al
    In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.
    Dig Dis Sci. 2019 Jul 6. pii: 10.1007/s10620-019-05717.
    PubMed     Abstract available
    
    
    
71. GAO B, Lang S, Duan Y, Wang Y, et al
    Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease.
    Dig Dis Sci. 2019;64:1878-1892.
    PubMed     Abstract available
    
    
    June 2019
72. SEMMLER G, Stift J, Scheiner B, Woran K, et al
    Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05702.
    PubMed     Abstract available
    
    
    
73. MARTIN M, Holmes S, Sim J, Hassan M, et al
    Foregone Inclusion: Neonatal CMV Hepatitis and Cholestasis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05691.
    PubMed    
    
    
    May 2019
74. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    PubMed     Abstract available
    
    
    
75. LEY D, Hayney MS, Caldera F
    Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 11. pii: 10.1007/s10620-019-05662.
    PubMed    
    
    
    April 2019
76. DING L, Gong Y, Yang Z, Zou B, et al
    Lactobacillus rhamnosus GG Ameliorates Liver Injury and Hypoxic Hepatitis in Rat Model of CLP-Induced Sepsis.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05628.
    PubMed     Abstract available
    
    
    
77. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Abstract available
    
    
    
78. VOILS CI, King HA, Thorpe CT, Blalock DV, et al
    Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05621.
    PubMed     Abstract available
    
    
    
79. LEE HL, Jang JW, Han JW, Lee SW, et al
    Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
    Dig Dis Sci. 2019 Apr 13. pii: 10.1007/s10620-019-05614.
    PubMed     Abstract available
    
    
    
80. PRATT PK JR, Nunes D, Long MT, Farraye FA, et al
    Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Apr 3. pii: 10.1007/s10620-019-05595.
    PubMed     Abstract available
    
    
    March 2019
81. AHMAD J, Reddy KR, Tillmann HL, Hayashi PH, et al
    Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury.
    Dig Dis Sci. 2019 Mar 29. pii: 10.1007/s10620-019-05591.
    PubMed     Abstract available
    
    
    
82. PATEL K, Zickmund SL, Jones H, Reid A, et al
    Determinants of Hepatitis C Treatment Adherence and Treatment Completion Among Veterans in the Direct Acting Antiviral Era.
    Dig Dis Sci. 2019 Mar 22. pii: 10.1007/s10620-019-05590.
    PubMed     Abstract available
    
    
    
83. FELD JJ, Krassenburg LAP
    What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05518.
    PubMed     Abstract available
    
    
    
84. CHEN YH, Lu SN, Wang JH, Hung CH, et al
    Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05571.
    PubMed     Abstract available
    
    
    February 2019
85. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Abstract available
    
    
    
86. WU T, Konyn PG, Cattaneo AW, Saab S, et al
    New Face of Hepatitis C.
    Dig Dis Sci. 2019 Feb 13. pii: 10.1007/s10620-019-05511.
    PubMed     Abstract available
    
    
    
87. KWON JH, Song MJ, Jang JW, Bae SH, et al
    Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05489.
    PubMed     Abstract available
    
    
    
88. PHAM C, Kuo A
    Minority Report: ENUMERATing Treatment of Chronic HBV Infection Among Asian-American Communities.
    Dig Dis Sci. 2019;64:289-291.
    PubMed    
    
    
    January 2019
89. DAKHOUL L, Jones KR, Gawrieh S, Ghabril M, et al
    Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jan 7. pii: 10.1007/s10620-018-5441.
    PubMed     Abstract available
    
    
    December 2018
90. SHETTY A, Buch A, Saab S
    Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5404.
    PubMed     Abstract available
    
    
    
91. LIU Y, Wang W, Zou Z, Hu Z, et al
    Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.
    Dig Dis Sci. 2018 Dec 10. pii: 10.1007/s10620-018-5401.
    PubMed     Abstract available
    
    
    November 2018
92. CHEN LY, Fan XP, Fan YC, Zhao J, et al
    BATF Interference Blocks Th17 Cell Differentiation and Inflammatory Response in Hepatitis B Virus Transgenic Mice.
    Dig Dis Sci. 2018 Nov 29. pii: 10.1007/s10620-018-5392.
    PubMed     Abstract available
    
    
    
93. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed    
    
    
    October 2018
94. CZAJA AJ, Montano-Loza AJ
    Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Oct 28. pii: 10.1007/s10620-018-5351.
    PubMed     Abstract available
    
    
    
95. CHANG ML, Liaw YF
    Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B.
    Dig Dis Sci. 2018 Oct 25. pii: 10.1007/s10620-018-5340.
    PubMed     Abstract available
    
    
    
96. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    PubMed     Abstract available
    
    
    
97. AHN SH, Marcellin P, Ma X, Caruntu FA, et al
    Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
    Dig Dis Sci. 2018 Oct 15. pii: 10.1007/s10620-018-5294.
    PubMed     Abstract available
    
    
    
98. KHALILI M, Wong RJ
    Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net.
    Dig Dis Sci. 2018 Oct 11. pii: 10.1007/s10620-018-5316.
    PubMed    
    
    
    September 2018
99. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Abstract available
    
    
    
100. LEE HM, Ahn J, Kim WR, Lim JK, et al
     A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
     Dig Dis Sci. 2018 Sep 20. pii: 10.1007/s10620-018-5281.
     PubMed     Abstract available
     
     
     
101. SHERMAN KE, Rouster SD, Kang M, Umbleja T, et al
     PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
     Dig Dis Sci. 2018 Sep 14. pii: 10.1007/s10620-018-5278.
     PubMed     Abstract available
     
     
     
102. WARDI J, Ernst O, Lilja A, Aeed H, et al
     3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism.
     Dig Dis Sci. 2018 Sep 8. pii: 10.1007/s10620-018-5267.
     PubMed     Abstract available
     
     
     August 2018
103. ZHANG G, Yu X, Liu P, Huang X, et al
     Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
     Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
     PubMed     Abstract available
     
     
     
104. AHN SH, Marcellin P, Ma X, Caruntu FA, et al
     Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
     Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5251.
     PubMed     Abstract available
     
     
     
105. MARSHALL MC, Herrera JL
     Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C.
     Dig Dis Sci. 2018 Aug 20. pii: 10.1007/s10620-018-5247.
     PubMed     Abstract available
     
     
     
106. SIKAVI C, Najarian L, Saab S
     Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection.
     Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5215.
     PubMed     Abstract available
     
     
     
107. TRAN AN, Sachdev R, Fricker ZP, Leber M, et al
     Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
     Dig Dis Sci. 2018 Aug 4. pii: 10.1007/s10620-018-5231.
     PubMed     Abstract available
     
     
     July 2018
108. STEWART RA, MacDonald BR, Chu TC, Moore JD, et al
     Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
     Dig Dis Sci. 2018 Jul 16. pii: 10.1007/s10620-018-5205.
     PubMed     Abstract available
     
     
     June 2018
109. KIM NH, Cho YK, Kim BI, Kim HJ, et al
     Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.
     Dig Dis Sci. 2018 Jun 12. pii: 10.1007/s10620-018-5165.
     PubMed     Abstract available
     
     
     May 2018
110. SHEN J, Liu J, Li C, Wen T, et al
     The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
     Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
     PubMed     Abstract available
     
     
     April 2018
111. CZAJA AJ
     Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.
     Dig Dis Sci. 2018 Apr 18. pii: 10.1007/s10620-018-5072.
     PubMed     Abstract available
     
     
     
112. SHAH R, Ho EY, Kramer JR, Richardson P, et al
     Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
     Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
     PubMed     Abstract available
     
     
     March 2018
113. ALEXANIAN D, Birg A, Volpicelli N, Glass J, et al
     Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
     Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5028.
     PubMed    
     
     
     
114. EFE C, Taii HA, Ytting H, Aehling N, et al
     Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
     Dig Dis Sci. 2018 Mar 22. pii: 10.1007/s10620-018-5011.
     PubMed     Abstract available
     
     
     
115. KAPLAN DE
     Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVR.
     Dig Dis Sci. 2018 Mar 17. pii: 10.1007/s10620-018-5014.
     PubMed    
     
     
     
116. ABDEL-MONEIM A, Aboud A, Abdel-Gabbar M, Zanaty M, et al
     Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients.
     Dig Dis Sci. 2018 Mar 15. pii: 10.1007/s10620-018-5005.
     PubMed     Abstract available
     
     
     
117. HU KQ, Cui W
     Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
     Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-4968.
     PubMed     Abstract available
     
     
     February 2018
118. TANEJA S, Duseja A, De A, Mehta M, et al
     Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
     Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4979.
     PubMed     Abstract available
     
     
     
119. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
     Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
     Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
     PubMed     Abstract available
     
     
     January 2018
120. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
     Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
     Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
     PubMed     Abstract available
     
     
     
121. ABDEL-HAMEED EA, Rouster SD, Boyce CL, Zhang X, et al
     Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.
     Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4895.
     PubMed     Abstract available
     
     
     
122. DONG J, Ying J, Qiu X, Lu Y, et al
     Advanced Strategies for Eliminating the cccDNA of HBV.
     Dig Dis Sci. 2018;63:7-15.
     PubMed     Abstract available
     
     
     December 2017
123. CAMPBELL B, Lopez A, Liu B, Bhuket T, et al
     A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital.
     Dig Dis Sci. 2017 Dec 5. pii: 10.1007/s10620-017-4870.
     PubMed     Abstract available
     
     
     
124. HOVAIDA M, Torrazza-Perez E, McCarthy D
     Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause.
     Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4849.
     PubMed    
     
     
     November 2017
125. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
     Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
     Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
     PubMed     Abstract available
     
     
     
126. KWAK YE, Stein SM, Lim JK
     Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
     Dig Dis Sci. 2017 Nov 24. pii: 10.1007/s10620-017-4850.
     PubMed     Abstract available
     
     
     October 2017
127. BOSCARINO JA, Moorman AC, Rupp LB, Zhou Y, et al
     Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution.
     Dig Dis Sci. 2017;62:2704-2712.
     PubMed     Abstract available
     
     
     September 2017
128. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
     A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
     Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
     PubMed     Abstract available
     
     
     
129. PARIKH ND, Fu S, Rao H, Yang M, et al
     Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
     Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
     PubMed     Abstract available
     
     
     
130. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
     Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
     Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
     PubMed     Abstract available
     
     
     
131. CHAN J, Gogela N, Zheng H, Lammert S, et al
     Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
     Dig Dis Sci. 2017 Sep 8. doi: 10.1007/s10620-017-4749.
     PubMed     Abstract available
     
     
     
132. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
     Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
     Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
     PubMed     Abstract available
     
     
     
133. PURNAK T, Efe C, Kav T, Wahlin S, et al
     Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
     Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4728.
     PubMed     Abstract available
     
     
     
134. DU JEONG I, Jung SW, Park BR, Lee BU, et al
     Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naive Patients with Chronic Hepatitis B.
     Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4737.
     PubMed     Abstract available
     
     
     August 2017
135. YAYA I, Roux P, Marcellin F, Salmon-Ceron D, et al
     Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
     Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4703.
     PubMed    
     
     
     July 2017
136. CZAJA AJ
     Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.
     Dig Dis Sci. 2017 Jul 14. doi: 10.1007/s10620-017-4675.
     PubMed     Abstract available
     
     
     June 2017
137. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
     Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
     Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
     PubMed     Abstract available
     
     
     
138. WU E, Yang M, Rao H, Fu S, et al
     Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
     Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4619.
     PubMed     Abstract available
     
     
     May 2017
139. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
     Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
     Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
     PubMed     Abstract available
     
     
     
140. LENCI I, Bosa A, Milana M, Baiocchi L, et al
     Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
     Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
     PubMed    
     
     
     April 2017
141. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
     Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
     Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
     PubMed     Abstract available
     
     
     February 2017
142. DURAISWAMY S, Sheffield JS, Mcintire D, Leveno K, et al
     Updated Etiology and Significance of Elevated Bilirubin During Pregnancy: Changes Parallel Shift in Demographics and Vaccination Status.
     Dig Dis Sci. 2017;62:517-525.
     PubMed     Abstract available
     
     
     January 2017
143. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
     Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
     Dig Dis Sci. 2017;62:264-272.
     PubMed     Abstract available
     
     
     June 2016
144. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
     Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
     Dig Dis Sci. 2016.
     PubMed     Abstract available
     
     
     April 2016
145. LIN XJ, Lao XM, Shi M, Li SP, et al
     Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
     Dig Dis Sci. 2016.
     PubMed     Abstract available
     
     
     
146. REICH JS, Farraye FA, Wasan SK
     Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
     Dig Dis Sci. 2016.
     PubMed     Abstract available
     
     
     
147. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
     Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
     Dig Dis Sci. 2016.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: